Abstract: Essential proteins play a vital role in the preparation of antibiotics, disease diagnosis, and understanding the structure of an organism. It is crucial for cell survival and is associated ...
United States Immigration and Customs Enforcement is leveraging Palantir’s generative artificial intelligence tools to sort and summarize immigration enforcement tips from its public submission form, ...
SIMI VALLEY, California.—The White House has greenlit a plan to design and build a frigate domestically as part of its proposed “Golden Fleet,” Navy Secretary John Phelan announced at the Reagan ...
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...
Want to see more of NewsNation? Get 24/7 fact-based news coverage with the NewsNation app or add NewsNation as a preferred source on Google! (NewsNation) — The U.S. Army announced Tuesday that it will ...
Defense Secretary Pete Hegseth is expressing support for the Army’s termination of a program that assessed the branch’s leadership selection process. He shared on social media platform X an image of a ...
The Army has cut a program it used in recent years to pick officers to lead battalions and brigades and select to the top enlisted leaders for those formations, the service’s Human Resources Command ...
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...
– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio ...
Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...
– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results